Evidence map›Paper›PMID 37435033›Full record

ArticleMediterranean journal of hematology and infectious diseases2023

Novel

Egzona Qipa, Muradiye Acar, Sureyya Bozkurt, Murat Buyukdogan, Hazal B Sonmez, Muge Sayitoglu, Yucel Erbilgin, Zeynep Karakaş, Veysel S Hançer

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Egzona QipaIstinye University, Institute of Health Sciences, Department of Medical Biology and Genetics, Istanbul, Turkey.
Muradiye AcarIstinye University, Faculty of Medicine, Department of Medical Genetics, Istanbul, Turkey.
Sureyya BozkurtIstinye University, Faculty of Medicine, Department of Medical Biology, Istanbul, Turkey.
Murat BuyukdoganDonegen, Genetic Diseases Diagnosis Center, İstanbul, Turkey.
Hazal B SonmezIstinye University, Institute of Health Sciences, Department of Medical Biology and Genetics, Istanbul, Turkey.
Muge SayitogluAziz Sancar Institute of Experimental Medicine, Department of Genetics, Istanbul University, Istanbul, Turkey.
Yucel ErbilginAziz Sancar Institute of Experimental Medicine, Department of Genetics, Istanbul University, Istanbul, Turkey.
Zeynep KarakaşIstanbul University, Istanbul Faculty of Medicine Pediatric Hematology Oncology Department, Istanbul, Turkey.
Veysel S HançerDonegen, Genetic Diseases Diagnosis Center, İstanbul, Turkey.
Istinye University · TRIstanbul University · TRIstanbul Medeniyet University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute lymphoblastic leukemia (ALL) is a malignant disease of hematopoietic stem cells. B cell ALL (B-ALL) is characterized by highly proliferative and poorly differentiated progenitor B cells in the bone marrow. Chromosomal rearrangements, aberrant cell signaling, and mutations lead to dysregulated cell cycle and clonal proliferation of abnormal B cell progenitors. In this study, we aimed to examine hot spot genetic variations in the

Indexed as

B-ALLIDH2IL2RARUNX1

Identifiers

PMID37435033
PMCPMC10332349
OpenAlexW4383998329

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.